Daumova, L., Manakov, D., Petrak, J., Sovilj, D., Behounek, M., Andera, L., Vit, O., Souckova, O., Havranek, O., Dolnikova, A., Renesova, N., Tuskova, L., Winkowska, L., Bettazova, N., Kupcova, K., Kalbacova, M. H., Sikorova, M., Trneny, M., & Klener, P. (2025). Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors. Cell death discovery, 11(1), 65. https://doi.org/10.1038/s41420-025-02341-y

Běhounek, M., Lipcseyová, D., Vít, O., Žáček, P., Talacko, P., Husková, Z., Kikerlová, S., Tykvartová, T., Wohlfahrt, P., Melenovský, V., Beneš, J., & Petrák, J. (2025). Biomarkers of RV Dysfunction in HFrEF Identified by Direct Tissue Proteomics: Extracellular Proteins Fibromodulin and Fibulin-5. Circulation. Heart failure, 18(3), e011984. https://doi.org/10.1161/CIRCHEARTFAILURE.124.011984

Majtan, T., Olsen, T., Sokolova, J., Krijt, J., Křížková, M., Ida, T., Ditrói, T., Hansikova, H., Vit, O., Petrak, J., Kuchař, L., Kruger, W. D., Nagy, P., Akaike, T., & Kožich, V. (2024). Deciphering pathophysiological mechanisms underlying cystathionine beta-synthase-deficient homocystinuria using targeted metabolomics, liver proteomics, sphingolipidomics and analysis of mitochondrial function. Redox biology, 73, 103222. https://doi.org/10.1016/j.redox.2024.103222

Vít, O., Talacko, P., Musil, Z., Hartmann, I., Pacák, K., & Petrák, J. (2023). Identification of Potential Molecular Targets for the Treatment of Cluster 1 Human Pheochromocytoma and Paraganglioma via Comprehensive Proteomic Characterization. Clinical Proteomics, 20(1), 39. https://doi.org/10.1186/s12014-023-09428-7

Vít, O., & Petrák, J. (2023). Autotaxin and Lysophosphatidic Acid Signalling: The Pleiotropic Regulatory Network in Cancer. Folia biologica, 69(5-6), 149–162. https://doi.org/10.14712/fb2023069050149

Vít, O., Patel, M., Musil, Z., Hartmann, I., Fryšák, Z., Miettinen, M., Pacák, K., & Petrák, J. (2021). Deep Membrane Proteome Profiling Reveals Overexpression of Prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity. Molecules (Basel, Switzerland), 26(21), 6567. https://doi.org/10.3390/molecules26216567

Vít, O., Harant, K., Klener, P., Man, P., & Petrák, J. (2019). A Three-pronged "Pitchfork" Strategy Enables an Extensive Description of the Human Membrane Proteome and the Identification of Missing Proteins. Journal of Proteomics, 204, 103411. https://doi.org/10.1016/j.jprot.2019.103411

Vít, O., & Petrák, J. (2017). Integral Membrane Proteins in Proteomics. How to Break Open the Black Box? Journal of Proteomics, 153, 8–20. https://doi.org/10.1016/j.jprot.2016.08.006

Vít, O., Man, P., Kádek, A., Hausner, J., Sklenář, J., Harant, K., Novák, P., Ščigelová, M., Woffendin, G., & Petrák, J. (2016). Large-scale Identification of Membrane Proteins Based on Analysis of Trypsin-protected Transmembrane Segments. Journal of Proteomics, 149, 15–22. https://doi.org/10.1016/j.jprot.2016.03.016

Toman, O., Kabíčková, T., Vít, O., Fišer, R., Poláková, K. M., Zach, J., Linhartová, J., Vyoral, D., & Petrák, J. (2016). Proteomic Analysis of Imatinib-resistant CML-T1 Cells Reveals Calcium Homeostasis as a Potential Therapeutic Target. Oncology Reports, 36(3), 1258–1268. https://doi.org/10.3892/or.2016.4945

Lorková, L., Ščigelová, M., Arrey, T. N., Vít, O., Pospíšilová, J., Doktorová, E., Klánová, M., Alam, M., Vočková, P., Maswabi, B., Klener, P., Jr, & Petrák, J. (2015). Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells. PLoS One, 10(8), e0135314. https://doi.org/10.1371/journal.pone.0135314

Klánová, M., Lorková, L., Vít, O., Maswabi, B., Molinský, J., Pospíšilová, J., Vočková, P., Mavis, C., Latečková, L., Kulvait, V., Vejmělková, D., Jakša, R., Hernandez, F., Trněný, M., Vokurka, M., Petrák, J., & Klener, P., Jr (2014). Downregulation of Deoxycytidine Kinase in Cytarabine-resistant Mantle Cell Lymphoma Cells Confers Cross-resistance to Nucleoside Analogs Gemcitabine, Fludarabine and Cladribine, but Not to Other Classes of Anti-lymphoma Agents. Molecular Cancer, 13, 159. https://doi.org/10.1186/1476-4598-13-159

Pospíšilová, J., Vít, O., Lorková, L., Klánová, M., Živný, J., Klener, P., & Petrák, J. (2013). Resistance to TRAIL in Mantle Cell Lymphoma Cells is Associated With the Decreased Expression of Purine Metabolism Enzymes. International Journal of Molecular Medicine, 31(5), 1273–1279. https://doi.org/10.3892/ijmm.2013.1302

Petrák, J., Pospíšilová, J., Šedinová, M., Jedelský, P., Lorková, L., Vít, O., Kolář, M., Strnad, H., Beneš, J., Sedmera, D., Červenka, L., & Melenovský, V. (2011). Proteomic and Transcriptomic Analysis of Heart Failure Due to Volume Overload in a Rat Aorto-caval Fistula Model Provides Support for New Potential Therapeutic Targets - Monoamine Oxidase a and Transglutaminase 2. Proteome Science, 9(1), 69. https://doi.org/10.1186/1477-5956-9-69